Report: 'Pharmacy Benefit Managers' profited billions by raising prices of 'specialty drugs'
The Pharmaceutical Care Management Association, which represents PBM's, called the FTC report baseless and "without substantiating evidence."
FTC releases second report slamming pharmacy benefit managers
Agency commissioners voted unanimously on Tuesday to publish the report, which makes similar allegations against the controversial drug middlemen as the agency’s first report released last summer — but relies on more data.
Pharmacy benefit managers have become too powerful
Pharmacy benefit managers make decisions about medication access that aren’t always based on the best interests of patients.
FTC report shows $7.3 billion in drug price inflation by leading pharmacy benefit managers
From 2017 to 2022, the companies marked up prices at their pharmacies by hundreds or thousands of percent, netting them $7.3 billion in revenue.
3 pharmacy benefit managers made $7.3B for increasing drug prices, according to report
The Federal Trade Commission (FTC) said prescription drug prices increased by 51% over a five-year period. Carrie Underwood Speaks Out About Performing At Trump's Inauguration | Billboard News The 40 greatest TV shows ever made that only lasted a single season Capital One sued by US watchdog alleging bank cheated customers out of $2 billion Elon Musk poised to occupy White House office space: report The Experimental General Motors V8 So Powerful It Was Nicknamed "The Killer" 12 Things Ace Hardware Employees Won’t Tell You Moment kitesurfing Olympian rescues drowning woman Christopher Reeve’s kids always said no to films about their dad.
FTC says pharmacy benefits managers marked-up generic drug prices for $7.3bn gain
Regulator’s report finds companies ‘hiked costs’ for a range of medicines, including cancer and HIV treatments
FTC: Pharmacy managers inflated drug prices by $7.3 billion
WASHINGTON >> The nation’s three largest pharmacy benefit managers have significantly marked up the prices of certain medicines, including for heart disease, cancer and HIV, at their affiliated pharmacies,
FTC Launches Inquiry of Single-Family Rental Home 'Mega Investors,' Issues PBM Report
"While this information is theoretically available to the public, institutional owners' holdings are challenging to identify ...
pharmaphorum11h
FTC doubles down on PBM criticism in new report
The new document focuses on the influence of PBMs over the market for specialty generic drugs for illnesses like cancer, ...
UnitedHealth, employer of slain exec Brian Thompson, found to have overcharged some cancer patients for drugs by over 1,000%
CVS Caremark Rx blasted the findings for cherry picking certain drugs in an effort to push what it called an 'anti-PBM' ...
Will Congress get another shot at PBM reform?
Click in for more news from The Hill{beacon} Health Care Health Care   The Big Story Congress missed a chance at PBM reforms.
CNN25d
Pharmacy benefit manager reform fails to make the cut in federal funding package
Pharmacy benefit managers serve as middlemen between ... nothing to benefit patients,” the Pharmaceutical Care Management Association said in a statement earlier this week.
Marketplace1mon
What is a pharmacy benefit manager, anyway?
New legislation introduced in both the House and Senate would make it illegal for one company to own both a pharmacy-benefit manager and a pharmacy. Pharmacy benefit managers, or PBMs, are ...
FTC releases new findings in drug price inflation investigation
A new report from the Federal Trade Commission is uncovering what appears to be a major driver of the high cost of ...
Benefits Pro6d
Illinois lawmaker seeks more oversight of pharmacy benefit managers, with new bill
The bill is similar to Pennsylvania's new law and would curb PBMs by setting rules for rebates, audits and specialty drug ...